Literature DB >> 8119974

Structure-activity studies of glucagon-like peptide-1.

K Adelhorst1, B B Hedegaard, L B Knudsen, O Kirk.   

Abstract

A series of analogs of glucagon-like peptide-1 (GLP-1) was made replacing each amino acid with L-alanine to identify side-chain functional groups required for interaction with the GLP-1 receptor. In the case of L-alanine being the parent amino acid, substitution was made with the amino acid found in the corresponding position in glucagon. Binding assays were performed using the cloned rat GLP-1 receptor, and receptor activation was monitored using RIN 2A18 plasma membranes. The analogs that showed the weakest receptor binding were further compared with native GLP-1 by circular dichroism spectroscopy to investigate possible conformational changes. We conclude that the side chains in positions 7, 10, 12, 13, and 15 are directly involved in the receptor interaction while positions 28 and 29 are important for GLP-1 to adapt the conformation recognized by the receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119974

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

Review 1.  Insulinotropic toxins as molecular probes for analysis of glucagon-likepeptide-1 receptor-mediated signal transduction in pancreatic beta-cells.

Authors:  G G Holz; C A Leech; J F Habener
Journal:  Biochimie       Date:  2000 Sep-Oct       Impact factor: 4.079

2.  The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties.

Authors:  D M Irwin; M Satkunarajah; Y Wen; P L Brubaker; R A Pederson; M B Wheeler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

Review 4.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

6.  3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.

Authors:  Raghuvir R S Pissurlenkar; Mushtaque S Shaikh; Evans C Coutinho
Journal:  J Mol Model       Date:  2007-08-04       Impact factor: 1.810

7.  Peptide lipidation stabilizes structure to enhance biological function.

Authors:  Brian P Ward; Nickki L Ottaway; Diego Perez-Tilve; Dejian Ma; Vasily M Gelfanov; Matthias H Tschöp; Richard D Dimarchi
Journal:  Mol Metab       Date:  2013-09-05       Impact factor: 7.422

8.  Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.

Authors:  S Runge; B S Wulff; K Madsen; H Bräuner-Osborne; L B Knudsen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

9.  Influence of selective fluorination on the biological activity and proteolytic stability of glucagon-like peptide-1.

Authors:  He Meng; Subrahmanian Tarakkad Krishnaji; Martin Beinborn; Krishna Kumar
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

10.  In vivo biological activity of exendin (1-30).

Authors:  Máire E Doyle; Patrick McConville; Michael J Theodorakis; Margaret M Goetschkes; Michel Bernier; Richard G S Spencer; Harold W Holloway; Nigel H Greig; Josephine M Egan
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.